JCAP vs TECH
Jefferson Capital, Inc (JCAP) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Jefferson Capital, Inc (JCAP) is a credit services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported JCAP revenue for 2025-09-30 was $150.8M. Net income was $150.2M. Revenue was down 1.2% from 2025-06-30 to 2025-09-30. JCAP currently screens at market cap $0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
JCAP currently screens at market cap $0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the JCAP and TECH stock pages for the full models.
Not investment advice.